These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 24287067)
1. Balancing risks and benefits of therapy for patients with favorable-risk limited-stage Hodgkin lymphoma: the role of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy alone. Hay AE; Meyer RM Hematol Oncol Clin North Am; 2014 Feb; 28(1):49-63. PubMed ID: 24287067 [TBL] [Abstract][Full Text] [Related]
2. ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma. Meyer RM; Gospodarowicz MK; Connors JM; Pearcey RG; Wells WA; Winter JN; Horning SJ; Dar AR; Shustik C; Stewart DA; Crump M; Djurfeldt MS; Chen BE; Shepherd LE; ; N Engl J Med; 2012 Feb; 366(5):399-408. PubMed ID: 22149921 [TBL] [Abstract][Full Text] [Related]
12. Reduced versus full doses of irradiation after 3 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine in early stage Hodgkin lymphomas: results of a randomized trial. Arakelyan N; Jais JP; Delwail V; Brière J; Moles-Moreau MP; Sénécal D; Berthou C; Desablens B; Colonna P; Andrieu JM; Cancer; 2010 Sep; 116(17):4054-62. PubMed ID: 20564152 [TBL] [Abstract][Full Text] [Related]
13. Outcome of patients older than 60 years with classical Hodgkin lymphoma treated with front line ABVD chemotherapy: frequent pulmonary events suggest limiting the use of bleomycin in the elderly. Stamatoullas A; Brice P; Bouabdallah R; Mareschal S; Camus V; Rahal I; Franchi P; Lanic H; Tilly H Br J Haematol; 2015 Jul; 170(2):179-84. PubMed ID: 25891777 [TBL] [Abstract][Full Text] [Related]
14. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma]. Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946 [TBL] [Abstract][Full Text] [Related]
15. Pohl-Pinkus constrictions of hair following chemotherapy for Hodgkin's disease. Williamson PJ; de Berker D Br J Haematol; 2005 Mar; 128(5):582. PubMed ID: 15725077 [No Abstract] [Full Text] [Related]
16. An individual patient-data comparison of combined modality therapy and ABVD alone for patients with limited-stage Hodgkin lymphoma. Hay AE; Klimm B; Chen BE; Goergen H; Shepherd LE; Fuchs M; Gospodarowicz MK; Borchmann P; Connors JM; Markova J; Crump M; Lohri A; Winter JN; Dörken B; Pearcey RG; Diehl V; Horning SJ; Eich HT; Engert A; Meyer RM; Ann Oncol; 2013 Dec; 24(12):3065-9. PubMed ID: 24121121 [TBL] [Abstract][Full Text] [Related]
17. Treating limited-stage nodular lymphocyte predominant Hodgkin lymphoma similarly to classical Hodgkin lymphoma with ABVD may improve outcome. Savage KJ; Skinnider B; Al-Mansour M; Sehn LH; Gascoyne RD; Connors JM Blood; 2011 Oct; 118(17):4585-90. PubMed ID: 21873543 [TBL] [Abstract][Full Text] [Related]
18. Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence. Seshachalam A; Karpurmath SV; Rathnam K; Raman SG; Janarthinakani M; Prasad K; Patil C; Anoop P; Reddy N; Anumula SK; Roopa SP; Golamari KR; Danthala M; Gunari P; Malipatil B; Rangarajan B; Udupa KS; Nandennavar M; Niraimathi K; Shewade HD J Glob Oncol; 2019 Nov; 5():1-13. PubMed ID: 31834832 [TBL] [Abstract][Full Text] [Related]
19. Children and Adolescent Hodgkin Lymphoma in Argentina: Long-term Results After Combined ABVD and Restricted Radiotherapy. Zubizarreta PA; Alfaro E; Guitter M; Sanchez La Rosa C; Galluzzo ML; Millán N; Fiandrino F; Felice MS J Pediatr Hematol Oncol; 2017 Nov; 39(8):602-608. PubMed ID: 28902084 [TBL] [Abstract][Full Text] [Related]